Business Description
Sensei Biotherapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US81728A1088
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 10.59 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.19 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -23.7 | |||||
3-Year EPS without NRI Growth Rate | -20.6 | |||||
3-Year FCF Growth Rate | -21.6 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.28 | |||||
9-Day RSI | 60.82 | |||||
14-Day RSI | 63.66 | |||||
6-1 Month Momentum % | 49.77 | |||||
12-1 Month Momentum % | -28.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.92 | |||||
Quick Ratio | 11.92 | |||||
Cash Ratio | 11.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 5.4 | |||||
Shareholder Yield % | 4.08 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -41.25 | |||||
ROA % | -36.13 | |||||
ROIC % | -306.29 | |||||
ROC (Joel Greenblatt) % | -402.66 | |||||
ROCE % | -38.76 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.58 | |||||
Price-to-Tangible-Book | 0.58 | |||||
EV-to-EBIT | 0.64 | |||||
EV-to-EBITDA | 0.66 | |||||
EV-to-FCF | 0.67 | |||||
Price-to-Net-Current-Asset-Value | 0.65 | |||||
Price-to-Net-Cash | 0.67 | |||||
Earnings Yield (Greenblatt) % | 156.25 | |||||
FCF Yield % | -85.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sensei Biotherapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.131 | ||
Beta | 0.16 | ||
Volatility % | 60.24 | ||
14-Day RSI | 63.66 | ||
14-Day ATR (€) | 0.073073 | ||
20-Day SMA (€) | 1.1372 | ||
12-1 Month Momentum % | -28.47 | ||
52-Week Range (€) | 0.506 - 1.68 | ||
Shares Outstanding (Mil) | 25.08 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sensei Biotherapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sensei Biotherapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Sensei Biotherapeutics Inc Frequently Asked Questions
What is Sensei Biotherapeutics Inc(HAM:407)'s stock price today?
When is next earnings date of Sensei Biotherapeutics Inc(HAM:407)?
Does Sensei Biotherapeutics Inc(HAM:407) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |